NovaCentrix PFI-600 Ink Powers Scalable Impedimetric Chemiresistors for Non-Invasive Diagnostics
The demand for low-cost, high-throughput, and user-friendly point-of-care diagnostics is driving significant innovation in sensor technology. A recent publication in ACS Omega, titled “A User-Centered Approach in the Development of a Label-Free Impedimetric Chemiresistor for H2O2,” highlights a crucial advancement in this field. This research details the development of a novel impedimetric chemiresistor (ICR) for hydrogen peroxide (H2O2) detection, designed with a strong emphasis on real-world applicability. Central to its scalable fabrication is the use of NovaCentrix’s advanced conductive inks.
The study, from researchers at the University of Toronto Mississauga, presents a proof-of-concept ICR as an initial step toward a non-invasive hypoglycemia diagnostic tool. The device features a two-electrode design fabricated using a low-cost, scalable roll-to-roll (R2R) flexographic printing technique. This high-throughput manufacturing method, enabled by the precise properties of NovaCentrix’s PFI-600 aqueous-based silver nanoparticle ink, is crucial for bridging the gap between laboratory innovation and successful real-world implementation in healthcare.
Why This Matters: Addressing the Translational Gap in Diagnostics
New sensing technologies often face a “translational gap,” where promising laboratory results struggle to become practical, real-world applications. This challenge is particularly acute in medical diagnostics, where factors like cost, scalability, ease of use, and reliability are critical for widespread adoption. The paper’s user-centered approach directly confronts these issues by integrating feedback from potential users throughout the design process, ensuring the resulting device is not only technically robust but also clinically relevant and intuitive.
Hypoglycemia, characterized by dangerously low blood sugar, requires rapid identification and treatment. Current diagnostic methods are often invasive or require specialized equipment, making them unsuitable for quick, decentralized assessment, especially in emergency situations. A non-invasive, point-of-care device for H2O2 detection, which can indirectly measure glucose levels via enzymatic reactions, offers a compelling solution. This research establishes the foundation for such a device, underscoring that early user engagement and scalable manufacturing are key to its eventual success.
The Foundational Role of NovaCentrix PFI-600 Silver Nanoparticle Ink
At the core of this innovative impedimetric chemiresistor is the conductive foundation provided by NovaCentrix’s PFI-600 aqueous-based silver nanoparticle ink. This specialized ink was pivotal in enabling the high-throughput, roll-to-roll (R2R) flexographic printing of the silver electrodes, a critical step for creating a scalable and cost-effective diagnostic platform. The researchers specifically chose PFI-600 ink for its 61% loading and optimal viscosity range (500–1200 cP at a shear rate of 10 s⁻¹ and 150–450 cP at a shear rate of 1000 s⁻¹), perfectly suited for flexographic printing processes.
The selection of PFI-600 ink directly contributed to the feasibility of fabricating thousands of electrodes in a short timeframe, a cornerstone of the R2R manufacturing approach. This capability is essential for producing disposable, low-cost sensors that can be widely deployed. Our conductive inks are meticulously engineered to deliver consistent performance across diverse printing methods and substrates, allowing researchers to focus on advanced device functionality without being constrained by material compatibility.
High-Throughput Fabrication and Electrode Reliability
The R2R flexographic printing process, significantly enhanced by NovaCentrix PFI-600 ink, enabled the rapid fabrication of silver electrodes on a 250 µm roll of poly(ethylene terephthalate) (PET) substrate. This method achieved an impressive rate of 2000 electrodes in less than 30 minutes, showcasing remarkable manufacturing efficiency. The printed electrodes were subsequently cured in under 30 seconds at 150 °C using infrared bulbs, with the R2R system operating at a rolling speed of 1 m/s.
Beyond speed, the quality and consistency of the printed electrodes are paramount for reliable sensor performance. Atomic force microscopy (AFM) analysis revealed a root-mean-square surface roughness of 29.4 nm and a thickness of 305 nm for the silver nanoparticle electrodes. Scanning electron microscopy (SEM) further confirmed a homogeneous distribution of the silver nanoparticles, vital for maintaining robust conductive pathways and preventing device malfunction. The electrochemical stability of these R2R-printed ICR electrodes was rigorously validated, showing an average real component of impedance (Zre) of 1.32 ± 1.01 Ω (N = 132) and a coefficient of variation (CoV) in Zre over 100 s remaining below 10%, indicative of excellent reproducibility.
Demonstrating Analytical Performance and Real-World Potential
The fabricated ICR device exhibited a linear impedance response to H2O2, with a robust limit-of-detection (LOD) of 3.7 mM and a dynamic range of 4–60 mM H2O2. These analytical figures of merit represent a critical step towards developing a functional non-invasive diagnostic. Crucially, the device underwent preliminary validation in human saliva, a complex biological matrix that often poses significant challenges for sensing technologies. The ability to perform reliably in saliva, with reproducible responses (CoV values
The integration of a zeolitic imidazolate framework-8 (ZIF-8) chemiresistive channel further augments the sensor’s capabilities. ZIF-8’s high biocompatibility, thermal and chemical stability, and uniform porosity make it an ideal material for H2O2 detection, where changes in its physical properties upon exposure translate into measurable impedance shifts. This synergistic combination of robust, R2R-printed electrodes and a stable sensing channel forms the core of a highly promising diagnostic platform.
From Lab to Life: The User-Centered Advantage in Action
A distinguishing characteristic of this research is its “user-centered approach,” which involved engaging emergency medical responders (ECSpeRT) from the University of Toronto Mississauga throughout the development process. This iterative design methodology, incorporating direct user feedback from initial ideation to prototype testing, ensures that the sensor meets real-world needs for usability, portability, and rapid, clear readouts. This proactive focus on practical considerations from the outset significantly increases the likelihood of successful translation from a laboratory prototype to a deployable healthcare technology.
The feedback gathered from users guided critical design choices, such as the need for a non-invasive, fast, and easy-to-interpret device. This approach ensures that the final product will be technically rigorous, practical, and truly usable in emergency response settings, directly addressing the critical unmet need for non-invasive hypoglycemia assessment. NovaCentrix is proud to support research that not only pushes the boundaries of materials science but also prioritizes the human element in technological development, ensuring innovations have a tangible impact.
Looking Ahead: Advancing Point-of-Care Diagnostics
This work represents a compelling demonstration of how advanced materials, coupled with innovative manufacturing techniques and a user-centered design philosophy, can accelerate the development of next-generation diagnostic tools. NovaCentrix’s PFI-600 silver nanoparticle ink played a foundational role in enabling the scalable, high-performance electrodes required for this impedimetric chemiresistor. As research continues to refine the sensor’s performance for glucose detection in unprocessed human saliva, the potential for a truly impactful, non-invasive hypoglycemia diagnostic tool moves closer to reality.
We are excited to see our conductive inks contributing to such vital research, paving the way for future innovations in point-of-care diagnostics and beyond. NovaCentrix remains committed to providing the advanced materials that empower researchers to transform ambitious concepts into tangible solutions that address global health challenges.
Read the full paper: Richards, A. K.; Castillo Barberi, R.; Van Houten, J.; Ogata, A. F. A User-Centered Approach in the Development of a Label-Free Impedimetric Chemiresistor for H2O2. ACS Omega 2026, 11, 1745–1756.